Oxford Global, San Diego, California
2016-10-03 & 2016-10-04
Oxford Global is proud to present its Biomarkers and Precision Medicine USA Congress 2016, 3-4 Oct 2016, Boston, USA. Our renowned congress will bring together over 250 attendees from pharmaceutical and biotechnology companies as well as academia. The global biomarkers market will be valued at $24.10 Billion in 2015. It is expected to grow at a CAGR of 13.58% to reach $45.55 Billion by 2020 making it one of the fastest growing sectors within the pharmaceutical industry. The 2 day exciting programme covers case studies from a range of therapeutic areas including, oncology, immune-oncology, cardiovascular diseases, metabolic diseases, autoimmune diseases, fibrotic disorders, diabetes and more in the pre-clinical and clinical arena. Do not miss out on the latest development sin companion diagnostics and precision medicine. Experts will also discuss presentations on NGS as a choice of diagnostics, microRNAs as a potential circulating biomarker of drug-induced liver injury and the potential of metabolomics profiling to understand disease process and therapy.
|
|
|
Invited Speakers:
|
|
The 5 Interactive Streams include: - Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
- Personalised Medicine, Companion Diagnostics & Patient Testing
- Innovations In Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
- Biomarker in Clinical Development & Clinical Trials
- Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing
|
|